
|Articles|February 1, 2004
- LCGC Europe-02-01-2004
- Volume 17
- Issue 2
Quo Vadis 21 CFR 11
Author(s)R.D. McDowall
In the welcome return of this column, Bob McDowall revisits the evolving topic of 21 CFR 11 compliance, as it applies to chromatographers. He examines the FDA's activities in 2003 and outlines the current status of its regulations over, and guidance for, electronic records issues.
Advertisement
Articles in this issue
about 22 years ago
Comprehensive Two-Dimensional Gas Chromatographyabout 22 years ago
Tissue Sample Preparation — Not the Same Old Grindabout 22 years ago
Broad Peaksabout 22 years ago
Analysis of Combinatorial Natural Products by HPLC and CENewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Mass Spectrometry–Driven Strategies for Membrane Protein–Targeted Drug Discovery
2
Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation
3
Ep. 43: An Introduction to Optical Photothermal Infrared (O-PTIR) Spectroscopy
4
Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk
5




